Patent applications and USPTO patent grants for Aton Pharma, Inc..The latest application filed is for "ocular drug delivery devices".
Patent | Date |
---|---|
Ocular Drug Delivery Devices App 20190133934 - JACOB; Jean Theresa ;   et al. | 2019-05-09 |
Stereoselective synthesis of metyrosine Grant 9,452,974 - Halloran , et al. September 27, 2 | 2016-09-27 |
Stereoselective Synthesis Of Metyrosine App 20140350284 - HALLORAN; Kevin John ;   et al. | 2014-11-27 |
Ocular Drug Delivery Devices App 20140187497 - JACOB; Jean Theresa ;   et al. | 2014-07-03 |
Ocular Drug Delivery Devices App 20110129516 - JACOB; Jean Theresa ;   et al. | 2011-06-02 |
Stereoselective Synthesis Of Metyrosine App 20110104765 - HALLORAN; Kevin John ;   et al. | 2011-05-05 |
Uses Of Trientine And Penicillamine As Countermeasures To Metal Contamination App 20090030079 - Levinson; Barry ;   et al. | 2009-01-29 |
Diamine and Iminodiacetic Acid Hydroxamic Acid Derivatives App 20090023718 - Miller; Thomas A. ;   et al. | 2009-01-22 |
Methods of treating cancer with HDAC inhibitors App 20060167103 - Bacopoulos; Nicholas G. ;   et al. | 2006-07-27 |
SEC | 0001142897 | ATON PHARMA INC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.